Literature DB >> 12028459

Advanced atherosclerosis in predialysis patients with chronic renal failure.

Tetsuo Shoji1, Masanori Emoto, Tsutomu Tabata, Eiji Kimoto, Kayo Shinohara, Kiyoshi Maekawa, Takahiko Kawagishi, Hideki Tahara, Eiji Ishimura, Yoshiki Nishizawa.   

Abstract

BACKGROUND: Atherosclerosis is advanced in hemodialysis patients as shown by increased intima-media thickness of carotid arteries (CA-IMT), although it is not established whether the advanced atherosclerosis results from hemodialysis treatment or from chronic renal failure. The purpose of this study was to evaluate the effects of hemodialysis and renal failure on CA-IMT in patients with chronic renal failure.
METHODS: CA-IMT was measured by high-resolution B-mode ultrasonography in 110 patients with chronic renal failure before starting dialysis (CRF group), and compared with CA-IMT of 345 hemodialysis patients (HD group) and 302 healthy control subjects. They were all nondiabetic and the three groups were comparable in age and gender.
RESULTS: As compared with the healthy control subjects, the CRF and HD groups had greater CA-IMTs, whereas CA-IMTs of the CRF and HD groups were not statistically different. There was no significant correlation between duration of hemodialysis and CA-IMT in the HD group. Multiple regression analysis in the total subjects indicated that presence of renal failure, but not being treated with hemodialysis, was a significant factor associated with increased CA-IMT independent of age, gender, blood pressure, smoking, high-density lipoprotein (HDL) and non-HDL cholesterol levels.
CONCLUSIONS: These results demonstrate that thickening of arterial wall is present in patients with chronic renal failure before starting hemodialysis treatment, and support the concept that advanced atherosclerosis in hemodialysis patients is due not to hemodialysis treatment, but to renal failure and/or metabolic abnormalities secondary to renal failure.

Entities:  

Mesh:

Year:  2002        PMID: 12028459     DOI: 10.1046/j.1523-1755.2002.00372.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  26 in total

1.  Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.

Authors:  Tetsuo Shoji; Ikuto Masakane; Yuzo Watanabe; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Cervical arteriosclerosis is associated with preoperative clinical symptoms in patients with cervical spondylotic myelopathy.

Authors:  Gentaro Kumagai; Kanichiro Wada; Sunao Tanaka; Toru Asari; Yasuyuki Ishibashi
Journal:  Eur Spine J       Date:  2020-11-09       Impact factor: 3.134

3.  Menopausal symptoms in women with chronic kidney disease.

Authors:  Katharine L Cheung; Marcia L Stefanick; Matthew A Allison; Erin S LeBlanc; Mara Z Vitolins; Nawar Shara; Glenn M Chertow; Wolfgang C Winkelmayer; Manjula Kurella Tamura
Journal:  Menopause       Date:  2015-09       Impact factor: 2.953

4.  High resolution 3D diffusion cardiovascular magnetic resonance of carotid vessel wall to detect lipid core without contrast media.

Authors:  Yibin Xie; Wei Yu; Zhaoyang Fan; Christopher Nguyen; Xiaoming Bi; Jing An; Tianjing Zhang; Zhaoqi Zhang; Debiao Li
Journal:  J Cardiovasc Magn Reson       Date:  2014-09-17       Impact factor: 5.364

5.  Atheroma progression in chronic kidney disease.

Authors:  Claudio Rigatto; Adeera Levin; Andrew A House; Brendan Barrett; Euan Carlisle; Adrian Fine
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 8.237

6.  Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Anh L Bui; Ronit Katz; Bryan Kestenbaum; Ian H de Boer; Linda F Fried; Joseph F Polak; Bruce A Wasserman; Mark J Sarnak; David Siscovick; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

7.  Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.

Authors:  Shoko Tsuchikura; Tetsuo Shoji; Naoko Shimomura; Ryusuke Kakiya; Masanori Emoto; Hidenori Koyama; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Journal:  BMC Nephrol       Date:  2010-04-27       Impact factor: 2.388

8.  Carotid intima-media thickness in children with end-stage renal disease on dialysis.

Authors:  A Gheissari; M Sirous; T Hajzargarbashi; R Kelishadi; A Merrikhi; A Azhir
Journal:  Indian J Nephrol       Date:  2010-01

Review 9.  Cardiovascular risk factors in patients with chronic kidney disease.

Authors:  Sarina van der Zee; Usman Baber; Sammy Elmariah; Jonathan Winston; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

Review 10.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.